2023
Aligning public health and public safety: Probation as a touchpoint to identify and link patients with opioid use disorder to opioid agonist treatment
Bromberg D, Galvez de Leon S, Litz T, Azbel L, Liberman A, Polonsky M, Dvoriak S, Saichuk N, Taxman F, Altice F. Aligning public health and public safety: Probation as a touchpoint to identify and link patients with opioid use disorder to opioid agonist treatment. PLOS Global Public Health 2023, 3: e0002349. PMID: 37910486, PMCID: PMC10619786, DOI: 10.1371/journal.pgph.0002349.Peer-Reviewed Original ResearchCriminal justice settingsOpioid use disorderBrief interventionUse disordersPrevalence of OUDProbation centersHIV prevention effortsJustice settingsMental healthHigh rateCommunity supervision settingsOAT servicesSBIRT interventionAgonist therapyHIV testingOpioid dependenceAgonist treatmentConsecutive individualsTreatment strategiesGeneral populationProbationSBIRTPrevention effortsSupervision settingParticipantsScaling up evidence-based approaches to tuberculosis screening in prisons
Charalambous S, Velen K, Rueda Z, Croda J, Herce M, Shenoi S, Altice F, Muyoyeta M, Telisinghe L, Grandjean L, Keshavjee S, Andrews J. Scaling up evidence-based approaches to tuberculosis screening in prisons. The Lancet Public Health 2023, 8: e305-e310. PMID: 36780916, DOI: 10.1016/s2468-2667(23)00002-6.Commentaries, Editorials and LettersConceptsIncidence of tuberculosisCase-finding strategyHigh tuberculosis burdenMinistry of HealthEvidence-based approachTuberculosis burdenTreatment cascadeTuberculosis screeningTuberculosis notificationsTuberculosis diagnosisGeneral populationCare programDiagnostic strategiesTuberculosisEvidence baseSystematic screeningHigh rateIncidenceScreeningSetting
2021
An expanding HIV epidemic among older adults in Ukraine: Implications for patient-centered care
Rozanova J, Zeziulin O, Rich KM, Altice FL, Kiriazova T, Zaviryukha I, Sosidko T, Gulati K, Carroll C, Shenoi SV. An expanding HIV epidemic among older adults in Ukraine: Implications for patient-centered care. PLOS ONE 2021, 16: e0256627. PMID: 34591848, PMCID: PMC8483339, DOI: 10.1371/journal.pone.0256627.Peer-Reviewed Original ResearchConceptsStandardized mortality ratioMortality rateCause standardized mortality ratioTime of diagnosisGeneral population ratesLate-stage HIVAge-matched groupHigh mortality ratePatient-centered careIncident HIVHIV diagnosisHIV testingHIV incidenceHIV treatmentHIV epidemicMortality ratioTreatment strategiesGeneral populationHIVMortality trendsAge groupsEECA countriesTreatment programSame calendar yearOlder people
2019
Online HIV information seeking and pre-exposure prophylaxis awareness among people who use drugs
Ranjit YS, Shrestha R, Copenhaver M, Altice FL. Online HIV information seeking and pre-exposure prophylaxis awareness among people who use drugs. Journal Of Substance Use And Addiction Treatment 2019, 111: 16-22. PMID: 32087834, PMCID: PMC7039922, DOI: 10.1016/j.jsat.2019.12.010.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV informationMethadone treatmentPre-exposure prophylaxis (PrEP) awarenessPre-exposure prophylaxisNew HIV diagnosesHIV-negative PWUDBehavior change continuumCross-sectional surveyMethods of preventionAddiction treatment programsHIV diagnosisImmunodeficiency virusInjection drugsHIV preventionHigh riskGeneral populationSex partnersOverall healthTreatment programPrEPDrugsPWUDChange continuumRisk
2018
A multisite, longitudinal study of risk factors for incarceration and impact on mental health and substance use among young transgender women in the USA
Hughto JMW, Reisner SL, Kershaw TS, Altice FL, Biello KB, Mimiaga MJ, Garofalo R, Kuhns LM, Pachankis JE. A multisite, longitudinal study of risk factors for incarceration and impact on mental health and substance use among young transgender women in the USA. Journal Of Public Health 2018, 41: 100-109. PMID: 29474682, PMCID: PMC6490767, DOI: 10.1093/pubmed/fdy031.Peer-Reviewed Original ResearchConceptsYoung transgender womenIllicit drug useRisk factorsTransgender womenRecent incarcerationDrug useSignificant independent predictorsIndividual risk factorsSubstance use disordersIndependent predictorsDepressive symptomsGeneral populationUse disordersMultilevel interventionsSomatic symptomsPoor healthRecent homelessnessMental healthStudy periodSubstance useWomenMixed effects modelsLongitudinal studySymptomsEffects model
2016
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees
Dolan K, Wirtz AL, Moazen B, Ndeffo-mbah M, Galvani A, Kinner SA, Courtney R, McKee M, Amon JJ, Maher L, Hellard M, Beyrer C, Altice FL. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. The Lancet 2016, 388: 1089-1102. PMID: 27427453, DOI: 10.1016/s0140-6736(16)30466-4.Peer-Reviewed Original ResearchConceptsHepatitis B virusHepatitis C virusViral hepatitisChronic hepatitis B virusBurden of HIVOpioid agonist therapyPrevalence of HIVTreatment of HIVIncarceration of peopleComprehensive literature searchAgonist therapyActive tuberculosisHIV transmissionC virusB virusGlobal burdenPrevention interventionsGeneral populationGlobal epidemiologyHIVDrug useTuberculosisLiterature searchLarge-scale outbreaksHepatitisPrevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners
Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, Moazen B, Wirtz AL, Verster A, Altice FL. Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners. The Lancet 2016, 388: 1115-1126. PMID: 27427456, DOI: 10.1016/s0140-6736(16)30769-3.Peer-Reviewed Original ResearchConceptsHepatitis B virusHepatitis C virusC virusB virusOpioid agonist therapySecondary prevention strategiesBlood-borne infectionsPrevalence of HIVOpioid use disorderPrevention of transmissionPublic health systemAgonist therapyEffective treatmentGeneral populationUse disordersPrevention strategiesPrisoner healthHealth systemInfectionHIVVirusTuberculosisAbsence of alternativesTherapyRisk environmentClinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis
Rich JD, Beckwith CG, Macmadu A, Marshall BDL, Brinkley-Rubinstein L, Amon JJ, Milloy MJ, King MRF, Sanchez J, Atwoli L, Altice FL. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. The Lancet 2016, 388: 1103-1114. PMID: 27427452, PMCID: PMC5504684, DOI: 10.1016/s0140-6736(16)30379-8.Peer-Reviewed Original ResearchConceptsClinical careCommunity-based health careJail settingsHealth careDelivery of careCommunity-based treatmentProvision of treatmentHIV/AIDSPrison health careHepatitis BViral hepatitisMiddle-income countriesC virusClinical managementHigh-income countriesGeneral populationMedical careMental illnessInfectious diseasesOptimal deliverySubstance useCareTransmissible diseasesHIVTuberculosis
2015
Validation of the ‘drinking expectancy questionnaire for men who have sex with men’ in Peru
Vagenas P, Wickersham JA, Calabrese SK, Lama JR, Benites CM, Pun M, Sanchez J, Altice FL. Validation of the ‘drinking expectancy questionnaire for men who have sex with men’ in Peru. Drug And Alcohol Review 2015, 34: 559-566. PMID: 26120824, PMCID: PMC4795987, DOI: 10.1111/dar.12282.Peer-Reviewed Original ResearchTransgender womenRisky sexual behaviorIntervention targetsHigh-risk MSMSexual behaviorAlcohol use disorderHigh-risk behaviorsSpanish versionPotential intervention targetsPeruvian MSMHIV epidemicGeneral populationUse disordersClinical practiceMSMShort instrumentTwo-factor structureFurther screeningProblematic drinkingExpectancyMenExploratory factor analysisExpectancy QuestionnairePopulationLarge population
2013
Alcohol use disorders and antiretroviral therapy among prisoners in Argentina
Alpert M, Wickersham JA, Vázquez M, Altice FL. Alcohol use disorders and antiretroviral therapy among prisoners in Argentina. International Journal Of Prison Health 2013, 9: 40-50. PMID: 24772187, PMCID: PMC3999974, DOI: 10.1108/17449201311310797.Peer-Reviewed Original ResearchConceptsAlcohol use disorderAntiretroviral therapyUse disordersSecondary HIV preventionCent of subjectsCross-sectional surveyHIV careSubstance abuse patternsMajority of participantsIndependent correlatesHIV preventionTreatment outcomesGeneral populationHIVHealth care reformAbuse patternsAUDIT scaleCurrent incarcerationDisordersTherapyOne-thirdCare reformOne-quarterParticipantsFuture efforts
2007
Improving the Care for HIV-Infected Prisoners: An Integrated Prison-Release Health Model
Springer S, Altice F. Improving the Care for HIV-Infected Prisoners: An Integrated Prison-Release Health Model. 2007, 535-555. DOI: 10.1007/978-0-387-71695-4_30.Peer-Reviewed Original ResearchAntiretroviral therapyHIV careViral loadHIV-1 RNA levelsCommunity settingsActive antiretroviral therapyComorbid medical conditionsHuman Services guidelinesNormal life expectancySerious psychiatric illnessSubstance use disordersHIV/AIDSDepartment of HealthHAART regimensCD4 countHIV diseaseHIV infectionChronic conditionsPsychiatric illnessMedical conditionsGeneral populationHealth care institutionsUse disordersHIVViral replication
2006
Trust and other Characteristics Associated with Health Care Utilization by Injection Drug Users
Ostertag S, Wright B, Broadhead R, Altice F. Trust and other Characteristics Associated with Health Care Utilization by Injection Drug Users. Journal Of Drug Issues 2006, 36: 953-974. DOI: 10.1177/002204260603600409.Peer-Reviewed Original Research